ICARES Medicus, Inc. (TPEX:6612)
121.00
-0.50 (-0.41%)
Apr 2, 2025, 1:30 PM CST
ICARES Medicus Revenue
In the year 2024, ICARES Medicus had annual revenue of 859.79M TWD with 42.01% growth. ICARES Medicus had revenue of 256.90M in the quarter ending December 31, 2024, with 84.32% growth.
Revenue
859.79M
Revenue Growth
+42.01%
P/S Ratio
6.01
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.15B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 859.79M | 254.34M | 42.01% |
Dec 31, 2023 | 605.45M | 93.60M | 18.29% |
Dec 31, 2022 | 511.85M | 117.93M | 29.94% |
Dec 31, 2021 | 393.92M | 31.25M | 8.62% |
Dec 31, 2020 | 362.67M | -56.70M | -13.52% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Oneness Biotech | 117.93M |
Lumosa Therapeutics | 39.15M |
Pegavision | 6.82B |
Center Laboratories | 1.62B |